Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study

• Main Authors: Giuseppe Armentaro (Author), Graziella D'Arrigo (Author), Marcello Magurno (Author), Alfredo F. Toscani (Author), Valentino Condoleo (Author), Sofia Miceli (Author), Velia Cassano (Author), Raffaele Maio (Author), Franco Arturi (Author), Giovanni Tripepi (Author), Giorgio Sesti (Author), Angela Sciacqua (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Heart failure (HF) represents a widespread health problem characterized by high morbidity and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients affected by HF with reduced ejection fraction (HFrEF). The aim of this study was to evaluate the effectiveness and durab...